Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2000-8-1
pubmed:abstractText
Experiments were designed to investigate the mechanisms underlying the diabetes-related impairment of the vasodilatations of the perfused mesenteric arterial bed induced by acetylcholine (ACh) and K(+). In streptozotocin (STZ)-diabetic rats, the ACh-induced endothelium-dependent vasodilatation was attenuated. The dose-response curves for ACh in control and diabetic rats were each shifted to the right by N(G)-nitro-L-arginine (L-NOARG) and by isotonic high K(+) (60 mM). The ACh dose-response curves under isotonic high K(+) were not different between control and diabetic rats. We also examined the vasodilatation induced by K(+), which is a putative endothelium-derived hyperpolarizing factor (EDHF). The mesenteric vasodilatation induced by a single administration of K(+) was greatly impaired in STZ-induced diabetic rats. Treatment with charybdotoxin plus apamin abolished the ACh-induced vasodilatation but enhanced the K(+)-induced response in controls and diabetic rats. After pretreatment with ouabain plus BaCl(2), the ACh-induced vasodilatation was significantly impaired and the K(+)-induced relaxation was abolished in both control and diabetic rats. The impairment of the endothelium-dependent vasodilatation of the mesenteric arterial bed seen in STZ-induced diabetic rats may be largely due to a defective vascular response to EDHF. It is further suggested that K(+) is one of the endothelium-derived hyperpolarizing factors and that the vasodilatation response to K(+) is impaired in the mesenteric arterial bed from diabetic rats.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-10078995, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-10519554, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-1373909, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-2112194, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-2164782, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-2217559, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-2242444, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-2543815, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-2547480, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-2851359, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-3019739, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-3074543, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-3140677, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-3495737, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-3816968, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-6253831, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-7199409, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-7732600, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-7736692, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-7738833, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-802670, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-8564216, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-8593700, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-8735642, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-8894182, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-9105696, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-9217885, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-9253857, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-9257918, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-9508817, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-9550942, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-9559887, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-9605555, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-9706026, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-9834033, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-9852331, http://linkedlifedata.com/resource/pubmed/commentcorrection/10821782-9915774
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
130
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
549-56
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Mechanisms underlying the attenuation of endothelium-dependent vasodilatation in the mesenteric arterial bed of the streptozotocin-induced diabetic rat.
pubmed:affiliation
Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University, Shinagawa-ku, Tokyo 142-8501, Japan.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't